AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Study: Patients can benefit from simplified antiretroviral treatments.
2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A large study shows that simplified antiretroviral treatment regimens containing Viramune (nevirapine) or efavirenz offer comparable efficacy and safety in patients who switched from a protease inhibitor (PI)-based regimen.
Viramune and efavirenz are both nonnucleoside reverse transcriptase inhibitors (NNRTIs).
They are used in combination with other antiviral therapies to treat patients with HIV-1 infection. The nucleoside reverse transcriptase inhibitor (NRTI), abacavir, was also evaluated in the study.
"These findings are significant because physicians are looking for alternatives to protease inhibitor regimens due to their high pill burden and food restrictions or concerns about metabolic side effects. NNRTIs like Viramune and efavirenz provide a viable option," said Jose M. Gatell, MD, PhD, senior consultant and head, infectious diseases & AIDS units of the Hospital Clinic in Barcelona and investigator for the study.
"These results offer additional evidence that VIRAMUNE has comparable efficacy to efavirenz in HIV-infected patients, which was demonstrated earlier this year in the 2NN ...
- Simplified antiretroviral regimen safe, effective.(Brief Article)
- Newspaper article from: AIDS Weekly June 10, 2002 700+ words
2002 JUN 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Anti-HIV maintenence therapy consisting solely of reverse transcriptase inhibitors provides benefits comparable with those of conventional regimens, with significantly reduced toxicity, researchers say. Dr.
- Simplified antiretroviral regimen safe, effective.
- Newspaper article from: Biotech Week June 12, 2002 700+ words
2002 JUN 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Anti-HIV maintenence therapy consisting solely of reverse transcriptase inhibitors provides benefits comparable with those of conventional regimens, with significantly reduced toxicity, researchers say. Dr.
- Vertex Reports 52% SVR 12 Rate for a 24-week Telaprevir-based Regimen in...
- Press release article from: Business Wire June 9, 2008 700+ words
...achieved SVR12 with 24-week telaprevir-based regimen CAMBRIDGE, Mass. -- Vertex Pharmaceuticals...treatment with a 24-week telaprevir-based regimen (12 weeks of telaprevir in combination...to receive a 24-week telaprevir-based regimen (12 weeks of telaprevir in combination...
- Amlodipine Based Regimen to Lower Blood Pressure, Reduces the Risk of New-Onset...
- Press release article from: PR Newswire September 6, 2006 700+ words
...patients who received the beta-blocker based regimen were at increased risk of new-onset...showed that patients on the amlodipine based regimen experienced an 11 percent reduction...patients taking the beta-blocker-based regimen. In addition, they had a 10 percent...
- AMLODIPINE BASED REGIMEN REDUCES RISK OF NEW-ONSET DIABETES.
- News wire article from: AsiaPulse News September 6, 2006 700+ words
...patients who received the beta-blocker based regimen were at increased risk of new-onset...showed that patients on the amlodipine based regimen experienced an 11 per cent reduction...patients taking the beta-blocker-based regimen. In addition, they had a 10 per cent...
- Taxotere-based regimen reduces prostate cancer patients' risk of death by 20%.
- Newspaper article from: Drug Week July 9, 2004 700+ words
...Hospital, found that the Taxotere-based regimen reduced patients' risk of death by...shows that treatment with a Taxotere-based regimen may help extend the lives of men with...metastatic prostate cancer, the Taxotere-based regimen provided significantly greater disease...
- Encouraging 48-Week Protease Inhibitor Resistance Data Reported.(from patients...
- Newspaper article from: AIDS Weekly March 12, 2001 700+ words
...31 patients treated with a Kaletra-based regimen was found to have protease-inhibitor...patients treated with a nelfinavir-based regimen. Furthermore, resistance to the nucleoside...had viral rebound on the Kaletra-based regimen than those on the nelfinavir-based...
- DHHS panel recommends Kaletra as part of protease inhibitor-based regimen.
- Newspaper article from: Biotech Week October 1, 2003 700+ words
...preferred protease inhibitor (PI)-based regimen for the treatment of patients new to...first published in 1996. The Kaletra-based regimen is one of only two regimens selected...new to therapy and for whom a PI- based regimen was appropriate. The preferred regimens...